VAERS Explorer
Back to explore

Report #2832335

Received Mar 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
16 yrs
State
AZ
Recovered
Unknown
Vaccinated
Feb 26, 2025
Onset
Feb 26, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARCELVARICELLA (VARIVAX)MERCK & CO. INC.1Y013350—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE; TE for VARIVAX that occurred on 02/24/2025 and the vaccine was also inadvertently administered on 02/26/2025; This spontaneous report was received from a health professional and refers to a 16-year-old male patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 24-FEB-2025, a temperature excursion (TE) for Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) occurred (-11.4C for 1 hour 0 minutes 0 seconds). On 26-Feb-2025, the patient was inadvertently vaccinated with a dose of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) 0.5mL / once (lot #Y013350, expiration date: 02-Aug-2026), administered for prophylaxis. The vaccine was reconstituted with sterile diluent, solution for injection (product storage error). The patient did not experience any adverse issues or side effects related to the administration of Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX) (no adverse event). No prior excursions were noted. No product quality complaint (PQC) was noted.; Reporter's Comments:

Other medications

Sterile diluent